InvestSMART

Cann Group Limited (ASX:CAN)

ALERT: Price-sensitive ASX Announcement for CAN
Current share price for CAN : $0.003 -0.003 (-50%)+
Release
29 Apr 2026 9:25AM
Price at Release
$0.006
Full Release
download
Summary
Cann Group Limited has made significant strides in its international expansion, reporting a strong third quarter of 2026 with the commencement of medicinal cannabis flower exports to the UK and securing AMRadV licenses in Germany to support further distribution in Europe. The company improved its cash flow from operations, reducing cash outflows by 82% compared to the previous corresponding period, and achieved a 42% increase in revenue over the prior quarter, up to $2.32 million. Cann Group anticipates revenue for FY2026 to be between $9.2 million to $10 million, despite an expected EBITDA loss. The company is exploring strategic partnerships to enhance growth and shareholder value, anticipating future updates before the financial year ends on 30 June 2026.
Key Points
  • Breakthrough into UK market with first export of dried flower
  • Secured German AMRadV licenses for product irradiation
  • Trump administration's reclassification of medical marijuana as less dangerous
  • Highest B2B orders of the financial year recorded
  • 82% improvement in cash outflows year-to-date
  • Revenue increased by 42% over the prior quarter
  • Exploring strategic partnerships and M&A opportunities
  • Anticipated FY2026 revenue between $9.2 million to $10 million
  • Expected update on strategic activities before 30 June
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.